TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Retinal function amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal function implicit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of the analyte in plasma (AUC0-72h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinical Response/Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Immunogenicity-GMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Primary Immunogenicity-SCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Primary Immunogenicity-GMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Grading of Pre-Treatment vs. Follow Up Images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse reactions within 7 days after each dose
Endpoint domain: Adverse events/effects
Primary endpoint: Seroconversion rates of neutralizing antibody against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Circulatory uric acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptom Relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in reliance on Rx medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Xerostomia questionnaire (XQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Xerostomia Inventory (XI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Root mean square of successive R-R differences (RMSSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes from Clinical Dementia Rating Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of sports-related injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of recurrent sports-related injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Time spent in range (70-180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mobility after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Resting Heart Rate Variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Center for Epidemiological Studies - Depression Scale (CESD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Carotid artery corrected flow time (FTc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assertiveness level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of study completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean quantitative RNAemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calculation rate of complete response (CR) and complete response with incomplete hematologic recovery (CRi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnostic rate of MDD2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unplanned ICU admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Arterial stiffness markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endothelial glycocalyx thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall tissue quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall tissue thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall tissue organization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total irritable bowel syndrome symptom severity score (IBS-SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC) of repotrectinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of repotrectinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and type of early complications after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Number and type of postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Active Motor Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Motor Evoked Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Corticosilent Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Spinal Reflexive Excitability Modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Balance function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Impressions of usability (Patients)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impressions of usability (Caregivers)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impressions of usability (Clinicians)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urinary Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Global Eating Pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite rate of postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of BIS prehospital via quality parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of BIS prehospital via a questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with therapeutic voriconazole trough concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior Chamber Cell Grade of 0 on Day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct insertion and fixation of laryngeal mask
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functional outcome of the upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcome of the lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants tolerating >=600mg of peanut protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMT of EV71 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Cigarettes Purchased
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sensitivity index of pupillometry test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation coefficient between RMSE score and surgeon's assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Facial-Vitiligo Area Scoring Index (F-VASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Tear Film Break-Up Time (TFBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arm Vascular Function at Rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Arm Vascular Function in Response to Exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Participant Satisfaction with Overall Intervention Experience
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Engagement in Group Call Intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cure Rate after complete treatment
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of hemodynamic instability events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prediction of Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SARS-CoV-2 presence in stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hematologic ≥ Very Good Partial Response (VGPR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Surgical repair outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of adverse events (AE) defined as DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Reach of Nutrition Interventions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pelvic Floor Impact Questionnaire (PFIQ-7)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptoms associated with post-COVID-19 syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammation associated with post-COVID-19 syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative stress associated with post-COVID-19 syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary fibrosis associated with post-COVID-19 syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in distance walked in six-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of normal spermatozoa morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Postural perception of the vertical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SmartPICC placement efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SmartPICC safety
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of in silico derived pace map
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's willingness to eat vegetables at breakfast
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nursery staff's ability to follow the protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence or absence of multi-drug resistant bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Presence or absence of Highly Resistant and Emerging Bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Presence or absence of Clostridioids difficile toxinogenic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Concentration of EQ143 in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CD4+ T cell count in epidermis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: OCT structural parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life - Limb Lymphoedema Quality of Life (LymQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Disability of the shoulder - Disabilities of the Arm, Shoulder and Hand (DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Initial response after switching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total sleep time in 5 days
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Self-Control Self-Management Scale (SCMS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Upper Extremity Performance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of therapeutic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum depression symptoms at 1 month after delivery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum depression symptoms at 2 months after delivery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum depression symptoms at 3 months after delivery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Density of Dopaminergic transporters (DAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent time in sensor glucose target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skin infection (episiotomy/tear)
Endpoint domain: Adverse events/effects
Primary endpoint: Neonatal fever
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage mortality
Endpoint domain: Mortality/survival
Primary endpoint: Sustained Heat Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enterococcus faecalis bacterial reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: COVID-19 incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Need for antiemetic medication
Endpoint domain: Adverse events/effects
Primary endpoint: Seconder Caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in retention force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Weeks with Suicidal ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality due to urosepsis
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients discharged home
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Fasted blood lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax of levodopa concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration for levodopa concentrations ≥ 50% of Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SNAP-IV parent rating score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knee society score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Visual analog pain scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Sensitivity and specificity of classification model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time From Zero to Infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Hope Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Stress Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of fall risks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of walking endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of balance control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of lower body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Global Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: late adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in size of the HIV-1 latent reservoir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastrointestinal tolerance of novel biscuit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Effect on intestinal microbial populations and SCFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-reported Wellness
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Collect glucose values (fasting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Collect glucose values (after a test meal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Healthcare Professionals' Attitudes towards Patients with Chronic Pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in functional outcomes measured by total scores of the Disabilities of Arm, Shoulder and Hand (DASH) questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional outcomes measured by total scores of the American Shoulder and Elbow Surgeons (ASES) questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quality of life indicators measured by the 5-level version of the EuroQol-5 Dimension questionnaire (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Markers of pancreatic fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to clinically important deterioration (CID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ctDNA occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ctDNA quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean mobility scores on the Timed-up-and-Go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean mobility scores on the 2-Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (e.g. injury) related to exergame use
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive function maintenance/improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in symptoms after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of axial involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Clearance of Warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incomplete Clearance of Warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthosis comfort score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to return of sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Device implantation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate beats per minute (BPM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse Events (AE) Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Ambulation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulation velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC:Barrier Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal pigment epithelium changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of COVID-19 infection symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Diabetic Retinopathy Severity Scale (DRSS) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Value of telephone interview/teleconsultation after discharge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: All cause pre-hospitalization death
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in HBsAg Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Laboratory abnormalities and type, frequency and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients for whom a CAR-T cell product could be prepared
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Weight from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Waist Circumference from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Heart Rate from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes